Skip to content

Clinical trials

Phase 2 Leukemia, Myeloid, Acute trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2 Country / region: South Korea Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20071
20081
20091
20101
20112
20121
20132
20141
20151
20172
20183
20192
20202
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated5
Unknown status5
Active, not recruiting2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Asan Medical Center5
Cooperative Study Group A for Hematology3
Samsung Medical Center2
Seoul National University Hospital2
Astellas Pharma Global Development, Inc.1
Astex Pharmaceuticals, Inc.1
Daiichi Sankyo1
GlaxoSmithKline1
Nohla Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute26
Leukemia7
Myelodysplastic Syndromes5
Leukemia, Myelomonocytic, Chronic3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Anemia, Refractory, with Excess of Blasts2
Blast Crisis2
Congenital Abnormalities2
Leukemia, Biphenotypic, Acute2
Leukemia, Myeloid, Accelerated Phase2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.